Added Value

 

In case of DILI suspicion MetaHeps GmbH assists you in answering two vital questions:

 

1) Is DILI really the cause for the observed liver damage?


2) In case of DILI, which drug has caused liver injury?

 


 

 



What important information can MetaHeps® testing provide to you?

 

Szenario 1): It is not DILI. 

►It’s safe to proceed with the clinical drug development. Regulatory endorsement.

 
Szenario 2a): Another drug than the study drug has caused the liver damage. 
It’s safe to proceed with the clinical drug development. Regulatory endorsement.
 
Szenario 2b):The combination of another drug X and the study drug has caused the liver damage (drug-drug interaction).
The study drug will obtain market approval if not taken together with drug X.
 
Szenario 3: The study drug has caused the liver damage.
Development of DILI biomarkers together with MetaHeps GmbH for identification of patients at risk.